Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results Director departure Appointed director
|
PRESSURE BIOSCIENCES INC (PBIO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/31/2023 |
4
| SCHUMACHER RICHARD T (President, CEO) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 1,264 shares
@ $0.87, valued at
$1.1k
|
|
05/31/2023 |
4
| PETERSON JEFFREY N (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 3,292 shares
@ $0.87, valued at
$2.9k
|
|
05/31/2023 |
4
| Urdea Michael S (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 796 shares
@ $0.87, valued at
$692.5 |
|
05/31/2023 |
4
| Lazarev Alexander V (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 1,041 shares
@ $0.87, valued at
$905.7 |
|
05/31/2023 |
4
| Pollack Kevin (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 808 shares
@ $0.87, valued at
$703 |
|
05/31/2023 |
4
| Mangiardi Vito J (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 174 shares
@ $0.87, valued at
$151.4 |
|
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2023 |
4
| SCHUMACHER RICHARD T (President, CEO) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted 427,532 options to buy
@ $1.5, valued at
$641.3k
|
|
01/20/2023 |
4
| Ting Edmund Y (Senior VP of Engineering) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted 127,860 options to buy
@ $1.5, valued at
$191.8k
|
|
01/20/2023 |
4
| Lazarev Alexander V (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted options to buy
@ $1.5, valued at
$0 |
|
01/20/2023 |
4
| Pollack Kevin (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted 218,960 options to buy
@ $1.5, valued at
$328.4k
|
|
01/20/2023 |
4
| Urdea Michael S (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted 187,680 options to buy
@ $1.5, valued at
$281.5k
|
|
01/20/2023 |
4
| PETERSON JEFFREY N (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted 414,460 options to buy
@ $1.5, valued at
$621.7k
|
|
01/20/2023 |
4
| Mangiardi Vito J (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Granted 203,320 options to buy
@ $1.5, valued at
$305k
|
|
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| SCHUMACHER RICHARD T (President, CEO) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 1,206 shares
@ $1.24, valued at
$1.5k
|
|
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/09/2022 |
4
| Pollack Kevin (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 771 shares
@ $1.24, valued at
$956 |
|
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/02/2022 |
4
| Urdea Michael S (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 600 shares
@ $1.69, valued at
$1k
|
|
08/02/2022 |
4
| Pollack Kevin (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 609 shares
@ $1.69, valued at
$1k
|
|
08/02/2022 |
4
| PETERSON JEFFREY N (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 2,481 shares
@ $1.69, valued at
$4.2k
|
|
08/02/2022 |
4
| Mangiardi Vito J (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 131 shares
@ $1.69, valued at
$221.4 |
|
08/02/2022 |
4
| Lazarev Alexander V (Chief Science Officer) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 784 shares
@ $1.69, valued at
$1.3k
|
|
08/02/2022 |
4
| SCHUMACHER RICHARD T (President, CEO) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 952 shares
@ $1.69, valued at
$1.6k
|
|
06/28/2022 |
4
| Lazarev Alexander V (Chief Science Officer) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 694 shares
@ $1.91, valued at
$1.3k
|
|
06/28/2022 |
4
| Mangiardi Vito J (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 116 shares
@ $1.91, valued at
$221.6 |
|
06/28/2022 |
4
| Urdea Michael S (Director) has filed a Form 4 on PRESSURE BIOSCIENCES INC
Txns:
| Acquired 531 shares
@ $1.91, valued at
$1k
|
|
|
|
|